Publication | Closed Access
TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
353
Citations
0
References
1999
Year
Lenercept failed to be beneficial, but insight into the role of TNF in MS exacerbations was gained.